ConductScience.org, home

Paper35720474

Expression of sphingosine-1-phosphate receptor 2 is correlated with migration and invasion of human colon cancer cells: A preliminary clinical study.

Yan J and 4 others. Oncol Lett, 2022. Cited by 5 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Expression of sphingosine-1-phosphate receptor 2 is correlated with migration and invasion of human colon cancer cells: A preliminary clinical study. Papers, record 35720474. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35720474

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Expression of sphingosine-1-phosphate receptor 2 is correlated with migration and invasion of human colon cancer cells: A preliminary clinical study.
PubMed
Journal
Oncol Lett
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.37
iCite
Revised in PubMed
2022-07-16
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yan JJunjun
2Chen YYi
3Wu QQibiao
4Shao LLe
5Zhou XXiqiao

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131863815Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.Pharmacol Ther2020https://conductscience.org/library/papers/31863815PubMed
228583134Sphingosine kinase 1 expression enhances colon tumor growth.J Transl Med2017https://conductscience.org/library/papers/28583134PubMed
323723450Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation.Blood2013https://conductscience.org/library/papers/23723450PubMed
426937138Sphingosine kinase 1 is upregulated with lysophosphatidic acid receptor 2 in human colorectal cancer.World J Gastroenterol2016https://conductscience.org/library/papers/26937138PubMed
522098666Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma.Liver Int2012https://conductscience.org/library/papers/22098666PubMed
627080739Sphingosine 1-phosphate receptor 2 (S1P2) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapy.Sci Rep2016https://conductscience.org/library/papers/27080739PubMed
721527515Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A.Blood2011https://conductscience.org/library/papers/21527515PubMed
826429117Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.Adv Biol Regul2016https://conductscience.org/library/papers/26429117PubMed
918058224Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.Breast Cancer Res Treat2008https://conductscience.org/library/papers/18058224PubMed
1019937366The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients.J Neurooncol2010https://conductscience.org/library/papers/19937366PubMed
1131826690Fingolimod (FTY720) reduces viability and survival and increases histone H3 acetylation in medulloblastoma cells.Pediatr Hematol Oncol2020https://conductscience.org/library/papers/31826690PubMed
1227160553Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2.Sci Rep2016https://conductscience.org/library/papers/27160553PubMed
1328075451The role of sphingolipid signalling in diabetes‑associated pathologies (Review).Int J Mol Med2017https://conductscience.org/library/papers/28075451PubMed
1425084322Systemic distribution, subcellular localization and differential expression of sphingosine-1-phosphate receptors in benign and malignant human tissues.Exp Mol Pathol2014https://conductscience.org/library/papers/25084322PubMed
1520889557
High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients.
Am J Pathol2010https://conductscience.org/library/papers/20889557PubMed
1612810709Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.J Biol Chem2003https://conductscience.org/library/papers/12810709PubMed
1726716409Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.Oncotarget2016https://conductscience.org/library/papers/26716409PubMed
1822500830S1PR2 links germinal center confinement and growth regulation.Immunol Rev2012https://conductscience.org/library/papers/22500830PubMed
1923954895Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond.Nat Rev Drug Discov2013https://conductscience.org/library/papers/23954895PubMed
2023273921Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer.Cancer Cell2013https://conductscience.org/library/papers/23273921PubMed

See all 51 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
39328328Targeting SNAI1-Mediated Colorectal Cancer Chemoresistance and Stemness by Sphingosine Kinase 2 Inhibition.World J Oncol2024https://conductscience.org/library/papers/39328328PubMed
38473211Critical Roles of the Sphingolipid Metabolic Pathway in Liver Regeneration, Hepatocellular Carcinoma Progression and Therapy.Cancers (Basel)2024https://conductscience.org/library/papers/38473211PubMed
36631680Sphingosine 1-phosphate receptor 2 promotes the onset and progression of non-alcoholic fatty liver disease-related hepatocellular carcinoma through the PI3K/AKT/mTOR pathway.Discov Oncol2023https://conductscience.org/library/papers/36631680PubMed

Download CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35720474

GET https://conductscience.org/api/papers/v1/35720474/references?page=2